comparemela.com
Home
Live Updates
Iv Choline Chloride Program - Breaking News
Pages:
Latest Breaking News On - Iv choline chloride program - Page 1 : comparemela.com
Protara Therapeutics Announces Third Quarter 2023 Financial Results and Business Update
Dosing is progressing well in ADVANCED-1EXP trial evaluating TARA-002 in NMIBC patients with CIS; preliminary results expected in 1H24Company init.
United states
Jesse shefferman
Klinische einheit
Justine omalley
Exchange commission
Protara therapeutics inc
Iv choline chloride program
Chugai pharmaceutical co ltd
Drug administration
Company contact
Protara therapeutics inc nasdaq
Lymphatic malformations
Chief executive officer
Bacillus calmette gu
Orphan drug designation
Rare pediatric disease designation
vimarsana © 2020. All Rights Reserved.